BELSOMRA (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the BELSOMRA drug offered from Merck Sharp & Dohme Corp.. This Orexin Receptor Antagonist [EPC],Orexin Receptor Antagonists [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | suvorexant |
| SUBSTANCE NAME: | SUVOREXANT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Orexin Receptor Antagonist [EPC],Orexin Receptor Antagonists [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-08-29 |
| END MARKETING DATE: | 0000-00-00 |
BELSOMRA HUMAN PRESCRIPTION DRUG Details:
| Item Description | BELSOMRA from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: | CIV
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2014-08-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-0005_d00b54da-7063-47e2-bb66-1c5723561200 |
| PRODUCT NDC: | 0006-0005 |
| APPLICATION NUMBER: | NDA204569 |
Other SUVOREXANT Pharmaceutical Manufacturers / Labelers:
